Photocure $PHO.OL stock pullback after Q2 is chance to buy

Photocure $PHO.OL PHO presented Q2 2019 numbers today, with most numbers landing very close to expectations.

Webcast: https://webtv.hegnar.no/presentation.php?webcastId=98041425

Press release: https://newsweb.oslobors.no/message/482310

Armchair Healthcare podcast interview with CEO Dan Schneider: https://twitter.com/MaxJacobsEdison/status/1151116879089586176

Trade active:

Trade very much active after two analyst BUY recommendations this week:
Edison, target price NOK 69.
Norne securities, target price NOK 64.

At the current shareprice of NOK 53 this represents a reasonable upside potential.

Trade active:

Trade still active, coming into a crucial phase where either a stop or new upwards movement can be triggered

Trade active:

With crucial Q3 presentation coming up, PHO still trades within clearly defined trading range.

Nice update from company today:
photocure.com/news/siu2019_athens/

Trade closed: target reached:

Safe choice is to end this trade today before Photocure Q3 presentation, as the stock has been known to make some drastic biotech sell the news moves.

We can note a nice 49 to 59 NOK swing on this trade.